Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FAUAN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,470
Award facts
- Contract value 100% obligated
- $3,469.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $3,469.63 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Zepbound 5 mg/0.5 ml pen injections. The award, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the company competed in unrestricted federal procurement. DMS Pharmaceutical Group Inc., headquartered in Park Ridge, Illinois, has been registered in the System for Award Management since 2001 and specializes in distributing comprehensive pharmaceutical products and medical consumables to federal agencies.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. The parent IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499.999 billion and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's established performance on numerous prior delivery orders and its comprehensive product portfolio spanning branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals position the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FAUAN?
SPE2DB26FAUAN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FAUAN worth?
The government has obligated $3,470 on SPE2DB26FAUAN.
Is contract SPE2DB26FAUAN an order under another contract?
Yes. SPE2DB26FAUAN is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FAUAN competed?
The extent of competition for SPE2DB26FAUAN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award